Trial Profile
Efficacy of Oral Leukotriene in long term therapy of mild and moderate obstructive sleep apnea syndrome (OSAS) in children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Feb 2013
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Budesonide
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Acronyms SB-OSAS
- 14 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2012 Actual initiation date changed from 1 Jan 2009 to 3 Jun 2008 as reported by European Clinical Trials Database.
- 27 Aug 2011 New trial record